F-1/A: RYOJBABA CO., LTD. Files Eighth Amendment to F-1 Registration Statement, Including Auditor Consent for U.S. IPO

RYOJBABA CO., LTD. has filed Pre-Effective Amendment No. 8 to its Form F-1 Registration Statement, primarily to include the consent of its independent registered public accounting firm, TAAD, LLP, and update its exhibit index, signaling continued progress towards its U.S. initial public offering.

Summary

• RYOJBABA CO., LTD. filed Pre-Effective Amendment No. 8 to its Form F-1 Registration Statement on May 30, 2025.
• The primary purpose of this amendment is to file Exhibit 23.1, the Consent of TAAD, LLP (the independent registered public accounting firm), and to amend and restate the exhibit index in Part II.
• No other changes were made to the Registration Statement, and the prospectus remains unchanged from Amendment No. 7 filed on May 8, 2025.
• The company is a Japanese entity with principal executive offices in Fukuoka, Japan.
• The filing details indemnification provisions for directors and officers under Japanese Companies Act and the company's articles of incorporation, including liability limitations for non-executive directors and corporate auditors, and a directors and officers liability insurance policy.
• Historical common equity transactions include an issuance of 100 common shares to Masataka Sakai for 5,000,000 JPY on January 5, 2015.
• The company underwent a forward stock split effective March 3, 2024, at a ratio of 1-for-1,000, increasing issued and outstanding common shares from 10,000 to 10,000,000.
• Details of warrant issuances and exchanges with HeartCore for consulting services related to the IPO are provided, culminating in the allotment of 300,000 stock acquisition rights to HeartCore on March 3, 2024, exercisable at $0.01 per share upon successful Nasdaq Capital Market or NYSE American listing.
• The company undertakes to file post-effective amendments for prospectus updates, fundamental changes, and distribution plan changes, and acknowledges SEC's stance on indemnification for Securities Act liabilities.

Sentiment

Score: 6

Explanation: The filing is a procedural step towards an IPO, which is generally positive, but it contains no new substantive financial or operational information. The explicit delay undertaking and the SEC's stance on indemnification add minor cautionary notes, but overall it's a neutral-to-slightly positive procedural update.

Positives

• Filing of auditor consent indicates continued procedural progress towards the initial public offering.
• The company has established indemnification provisions and D&O insurance for its directors and officers, aligning with corporate governance best practices.
• The stock split and stock acquisition rights for HeartCore are part of the pre-IPO structuring, indicating active preparation for a public listing.

Negatives

• This amendment does not contain new financial or operational updates, as the prospectus remains unchanged from a prior amendment.
• The document does not provide new information regarding the company's business operations or financial performance.

Risks

• The U.S. Securities and Exchange Commission's opinion that indemnification for liabilities arising under the Securities Act is against public policy and unenforceable, which could expose directors, officers, and controlling persons to greater personal liability.
• The company's undertaking to delay the effective date of the registration statement until a further amendment is filed or the SEC determines effectiveness, indicating the IPO is not yet finalized and its timing remains uncertain.

Future Outlook

The company is progressing towards its initial public offering in the U.S., aiming for a listing on the Nasdaq Stock Market, New York Stock Exchange, or NYSE American. The effective date of the registration statement is subject to further amendment or SEC determination, indicating the IPO is not yet imminent but is actively being pursued.

Management Comments

• The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant files a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement becomes effective on such date as the Commission, acting pursuant to Section 8(a), may determine.

Industry Context

This filing is a standard procedural step in the U.S. IPO process for a foreign private issuer. The inclusion of auditor consent is a necessary component for the SEC to declare a registration statement effective. The detailed history of warrant issuances and a spin-off transaction highlights the complex pre-IPO restructuring often undertaken by companies seeking a U.S. listing, particularly those with prior holding company structures or consultant compensation arrangements.

Corporate Governance

Related Party Transactions

• Issuance of an Original Warrant, subsequent New Warrant, and Second New Warrant, culminating in 300,000 stock acquisition rights to HeartCore for consulting services related to the proposed initial public offering. HeartCore is a consultant to the company.

Stakeholder Impact

• Shareholders: The stock split has adjusted the number of shares outstanding, and the IPO, once effective, will introduce new public shareholders. Existing shareholders will be impacted by the terms of the IPO and the potential dilution from the exercise of stock acquisition rights.
• Directors and Officers: Indemnification provisions and D&O insurance aim to protect them from certain liabilities, though the SEC's stance on Securities Act liabilities remains a point of consideration.
• HeartCore: As a consultant, HeartCore has received significant stock acquisition rights tied to the successful IPO, aligning its interests with the company's listing success.

Next Steps

• Filing of a further amendment to specifically state the effective date of the registration statement.
• SEC determination of the effective date of the registration statement.
• Completion of the initial public offering and listing on Nasdaq, NYSE, or NYSE American.
• Potential exercise of stock acquisition rights by HeartCore upon successful listing.

Key Dates

Keywords

RYOJBABA CO., LTD., F-1/A, SEC filing, IPO, Initial Public Offering, Registration Statement, Auditor Consent, TAAD LLP, Stock Split, Warrant, Stock Acquisition Rights, Corporate Governance, Indemnification, Japan, Nasdaq, NYSE American